Virbac SA (EPA:VIRP)
314.50
+4.35 (1.40%)
May 2, 2025, 5:35 PM CET
Virbac Company Description
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in Europe, North America, Latin America, East Asia, India, Africa & Middle East, and Pacific.
The company offers a range of vaccines, antibiotics, parasiticides, anti-inflammatory drugs, dermatology, dental, specialties, diagnosis, and nutrition, as well as petfood and pharmaceutical products.
It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Virbac SA

Country | France |
Founded | 1968 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 5,620 |
CEO | Habib Ramdani |
Contact Details
Address: 13e rue LID - BP 27 Carros, 06511 France | |
Phone | 33 4 92 08 71 00 |
Website | corporate.virbac.com |
Stock Details
Ticker Symbol | VIRP |
Exchange | Euronext Paris |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | FR0000031577 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Marc Bistuer | Deputy Chief Executive Officer and Head of Compliance and Corporate Quality Assurance |
Habib Ramdani | Interim Chief Executive Officer and Chief Financial Officer |
Bertrand Havrileck | Head of Corporate Research & Development |